Hanneke Schuitemaker

1988–2025 年に発表

139
論文数
25,262
被引用数
88
h 指数
135
i10 指数

被引用数

Hanneke Schuitemaker の年別被引用数1989 年: 被引用 3 件1990 年: 被引用 3 件1991 年: 被引用 6 件1992 年: 被引用 22 件1993 年: 被引用 53 件1994 年: 被引用 78 件1995 年: 被引用 67 件1996 年: 被引用 89 件1997 年: 被引用 136 件1998 年: 被引用 154 件1999 年: 被引用 172 件2000 年: 被引用 138 件2001 年: 被引用 142 件2002 年: 被引用 125 件2003 年: 被引用 106 件2004 年: 被引用 94 件2005 年: 被引用 112 件2006 年: 被引用 85 件2007 年: 被引用 79 件2008 年: 被引用 77 件2009 年: 被引用 74 件2010 年: 被引用 95 件2011 年: 被引用 109 件2012 年: 被引用 112 件2013 年: 被引用 111 件2014 年: 被引用 71 件2015 年: 被引用 79 件2016 年: 被引用 133 件2017 年: 被引用 153 件2018 年: 被引用 137 件2019 年: 被引用 441 件2020 年: 被引用 565 件2021 年: 被引用 1,721 件2022 年: 被引用 1,288 件2023 年: 被引用 512 件2024 年: 被引用 616 件2025 年: 被引用 214 件2026 年: 被引用 6 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,437 件、この内訳の 34.4%イギリス: 引用元論文 719 件、この内訳の 7.2%オランダ: 引用元論文 533 件、この内訳の 5.3%中国: 引用元論文 430 件、この内訳の 4.3%ドイツ: 引用元論文 378 件、この内訳の 3.8%フランス: 引用元論文 374 件、この内訳の 3.7%カナダ: 引用元論文 331 件、この内訳の 3.3%イタリア: 引用元論文 286 件、この内訳の 2.9%ベルギー: 引用元論文 235 件、この内訳の 2.4%南アフリカ: 引用元論文 230 件、この内訳の 2.3%オーストラリア: 引用元論文 221 件、この内訳の 2.2%スペイン: 引用元論文 206 件、この内訳の 2.1%
0%34.4%その他 26.1%

分野

  • Medicine50%
  • Immunology and Microbiology39.5%
  • Biochemistry, Genetics and Molecular Biology6.9%
  • Social Sciences1.2%
  • Agricultural and Biological Sciences0.4%
  • Mathematics0.4%
  • その他1.6%

トピック

  • HIV Research and Treatment13.5%
  • SARS-CoV-2 and COVID-19 Research12.3%
  • Immune Cell Function and Interaction6.2%
  • COVID-19 Clinical Research Studies5.7%
  • HIV/AIDS drug development and treatment4.5%
  • HIV/AIDS Research and Interventions3.4%
  • その他54.4%

共著者

全論文

検索で開く
  1. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 2,601

  2. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

    著者: , , , , , , , , , , - Nature Communications 2015 被引用: 387

  3. Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 250

  4. Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 1,184

  5. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances Priddy, Erica Lazarus, Fatima Laher, Sorachai Nitayapan, Punnee Pitisuttithum, Stephan Bart, Thomas Campbell, Robert Feldman, Gregg Lucksinger, Caroline Borremans, Katleen Callewaert, Raphaele Roten, Jerald Sadoff, Lorenz Scheppler, Mo Weijtens, Karin Feddes-de Boer, Daniëlle van Manen, Jessica Vreugdenhil, Roland Zahn, Ludo Lavreys, Steven Nijs, Jeroen Tolboom, Jenny Hendriks, Zelda Euler, Maria Grazia Pau, Hanneke Schuitemaker - The Lancet 2018 被引用: 342

  6. Complex-type N -glycan recognition by potent broadly neutralizing HIV antibodies

    著者: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 581

  7. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology

    著者: , , , , , , , , , , , , , , , , , , , , , - Cell 2015 被引用: 371

  8. Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Makda S. Gebre, Emily Hoffman, Catherine Jacob-Dolan, Marinela Kirilova, Zhenfeng Li, Zijin Lin, Shant H. Mahrokhian, Lori F. Maxfield, Felix Nampanya, Ramya Nityanandam, Joseph P. Nkolola, Shivani Patel, John D. Ventura, Kaylee Verrington, Huahua Wan, Laurent Pessaint, Alex Van Ry, Kelvin Blade, Amanda Strasbaugh, Mehtap Cabus, Renita Brown, Anthony Cook, Serge Zouantchangadou, Elyse Teow, Hanné Andersen, Mark G. Lewis, Yongfei Cai, Bing Chen, Aaron G. Schmidt, R. Keith Reeves, Ralph S. Baric, Douglas A. Lauffenburger, Galit Alter, Paul Stoffels, Mathai Mammen, Johan Van Hoof, Hanneke Schuitemaker, Dan H. Barouch - Nature 2020 被引用: 907

  9. Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Avi Kenny, Marco Carone, Daniel Wolfe, Jerald Sadoff, Glenda Gray, Beatriz Grinsztejn, Paul Goepfert, Susan J. Little, Leonardo Paiva de Sousa, Rebone Maboa, April K. Randhawa, Michele P. Andrasik, Jenny Hendriks, Carla Truyers, Frank Struyf, Hanneke Schuitemaker, Macaya Douoguih, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Dean Follmann, Peter B. Gilbert, Richard A. Koup, Rubén O. Donis, on behalf of the Immune Assays Team, the Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team, and the United States Government (USG)/CoVPN Biostatistics Team - Nature Microbiology 2022 被引用: 93

  10. Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rogier W. Sanders - Cell 2015 被引用: 380

  11. Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 330

  12. Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitri Goedhart, Michael C. Keefer, Colleen Kelly, Ken Mayer, Joseph P. Nkolola, Lauren Peter, Merlin L. Robb, Nadine Rouphael, Lorenz Scheppler, Magda Sobieszczyk, Hong‐Van Tieu - The Lancet HIV 2020 被引用: 91

  13. Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years

    著者: , , , , , , , , , , , - The Journal of Infectious Diseases 2020 被引用: 111

  14. Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

    著者: , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 被引用: 90

  15. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fei Chen, Polan Chetty, Pei-Ling Chu, Kimberly L. Cooper, Jerome Custers, Hilde Delanghe, A. Duca, Tracy Henrick, Jarek Juraszek, Catherine Nalpas, Monika Peeters, José Cirı́aco Pinheiro, Sanne Roels, Martin Ryser, José A. Salas, Samantha Santoro Matias, Ilse Scheys, Pallavi Shetty, Georgi Shukarev, Jeffrey J. Stoddard, Willem Talloen, NamPhuong Tran, Nathalie Vaissière, Elisabeth van Son-Palmen, Jiajun Xu, Erin A. Goecker, Alexander L. Greninger, Keith R. Jerome, Pavitra Roychoudhury, Simbarashe Takuva, J.L. Mendoza, Eric D. Achtyes, Habibul Ahsan, Azhar Alhatemi, Nancy A. Allen, José Ramón Arribas, Ghazaleh Bahrami, Lucía Bailón, Ali Ahsan Bajwa, Jonathan Baker, Mira Baron, Susana Benet, Driss Berdaï, Patrick Berger, Todd Bertoch, Claire Bethune, Sybille Bevilacqua, Maria Silvia Biagioni Santos, Ian Binnian, Karen Bisnauthsing, Jean‐Marc Boivin, Hilde Bollen, Sandrine Bonnet, Alberto M. Borobia, Élisabeth Botelho-Nevers, Phil Bright, Vianne Britten, Claire Brown, Amanda Buadi, Erik Buntinx, Lesley Burgess, Larry M. Bush, María Rosario Capeding, Quito Osuna Carr, Amparo Carrasco Mas, Hélène Catalá, Katrina Cathie, T S Caudill, Fernando Cereto Castro, Kénora Chau ほか 190 名 - The Lancet Infectious Diseases 2022 被引用: 88

  16. Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan Buchbinder, Trevor A. Crowell, Zelda Euler, Ian Frank, Dimitri Goedhart, Jennifer Johnson, Michael C. Keefer, Colleen F. Kelley, Kenneth H. Mayer, Joseph P. Nkolola, Lauren Peter, Merlin L. Robb, Nadine Rouphael, Lorenz Scheppler, Magda Sobieszczyk, Hong‐Van Tieu, Matthew H. Collins, Varun K. Phadke - The Journal of Infectious Diseases 2022 被引用: 36

  17. Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2016 被引用: 272

  18. Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 256

  19. A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers

    著者: , , , , , , , , , , , , - Cell Reports 2018 被引用: 116

  20. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Diane G. Kanjilal, Caitlin J. Guiney, Connor Bradshaw, Anna L. Tyler, Tatenda Makoni, Katherine E. Yanosick, Michael S. Seaman, Douglas A. Lauffenburger, Galit Alter, Frank Struyf, Macaya Douoguih, Johan Van Hoof, Hanneke Schuitemaker, Dan H. Barouch - JAMA 2021 被引用: 336

  21. Inactivated Viral Vaccines

    著者: , , - Vaccine Analysis: Strategies, Vaccine Analysis: Strategies, Principles, and Control 2014 被引用: 162

  22. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates

    著者: , , , , , , , , , , , , , , , , , , , , - PLoS ONE 2018 被引用: 94

  23. Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - npj Vaccines 2020 被引用: 74

  24. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nelson Michael, Merlin L. Robb, Frank Tomaka, Jintanat Ananworanich - Nature Medicine 2020 被引用: 72